Cargando…

Retention in the Austrian opioid agonist treatment system: a national prospective cohort study

BACKGROUND: Retention in care is a prerequisite for successful recovery, especially for a chronic condition like opioid dependence. Though retention varies greatly depending on the different substitution medication and treatment model, treatment retention is used as an indicator of treatment quality...

Descripción completa

Detalles Bibliográficos
Autores principales:	Busch, Martin, Klein, Charlotte, Uhl, Alfred, Haltmayer, Hans, Cabanis, Maurice, Westenberg, Jean Nicolas, Vogel, Marc, Krausz, R. Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7903033/ https://www.ncbi.nlm.nih.gov/pubmed/33627159 http://dx.doi.org/10.1186/s12954-021-00473-9

Ejemplares similares

Chronic Pain among Individuals Experiencing Homelessness and Its Interdependence with Opioid and Other Substance Use and Mental Illness
por: Vogel, Marc, et al.
Publicado: (2021)

Effectiveness and cost-effectiveness of sector-independent treatment coordination for people with substance-related disorders following an online assessment (ASSIST): study protocol for a randomized controlled trial
por: Mueller-Stierlin, Annabel S., et al.
Publicado: (2022)

The upcoming synthetic ultrapotent opioid wave as a foreseeable disaster
por: Krausz, R Michael, et al.
Publicado: (2022)

Risk and protective factors for opioid overdose during the COVID-19 pandemic
por: Wong, J., et al.
Publicado: (2021)

Benzodiazepine use, quality of life and psychiatric symptom burden in oral and injectable opioid agonist treatment: a cross-sectional study
por: Meyer, Maximilian, et al.
Publicado: (2023)

Sexual dysfunction prevalence, risk factors, and help-seeking behavior in opioid agonist treatment and general psychiatry: a cross-sectional study
por: Meyer, Maximilian, et al.
Publicado: (2023)

Negative Impact of Amphetamine-Type Stimulant Use on Opioid Agonist Treatment Retention in Ontario, Canada
por: Morin, Kristen A., et al.
Publicado: (2021)

Prospective study of retention in opioid agonist treatment and contact with emergency healthcare following release from prisons in Victoria, Australia
por: Curtis, Michael, et al.
Publicado: (2023)

Results of the Austrian National Lung Cancer Audit
por: Burghuber, Otto C, et al.
Publicado: (2020)

Feasibility, safety, and acceptability of intranasal heroin-assisted treatment in Switzerland: protocol for a prospective multicentre observational cohort study
por: Westenberg, Jean N., et al.
Publicado: (2023)

Case report: acute care management of severe opioid withdrawal with IV fentanyl
por: Azar, Pouya, et al.
Publicado: (2022)

The effect of entry and retention in opioid agonist treatment on contact with the criminal justice system among opioid-dependent people: a retrospective cohort study
por: Gisev, Natasa, et al.
Publicado: (2019)

High retention in an opioid agonist therapy project in Durban, South Africa: the role of best practice and social cohesion
por: Marks, Monique, et al.
Publicado: (2020)

Forecasting Austrian national elections: The Grand Coalition model
por: Aichholzer, Julian, et al.
Publicado: (2014)

Retention in opioid agonist treatment: a rapid review and meta-analysis comparing observational studies and randomized controlled trials
por: Klimas, Jan, et al.
Publicado: (2021)

Characterizing opioid agonist therapy uptake and factors associated with treatment retention among people with HIV in British Columbia, Canada
por: Yazdani, Kiana, et al.
Publicado: (2023)

Better agonist for the opioid receptors
por: Badshah, Syed Lal, et al.
Publicado: (2018)

Use of microdoses for induction of buprenorphine treatment with overlapping full opioid agonist use: the Bernese method
por: Hämmig, Robert, et al.
Publicado: (2016)

Towards an International Consensus on the Prevention, Treatment, and Management of High-Risk Substance Use and Overdose among Youth
por: Krausz, Michael, et al.
Publicado: (2022)

Austrian visit
Publicado: (2003)

Austrian Contribution
Publicado: (1959)

Austrian Women
Publicado: (1891)

Combining treatment for chronic hepatitis C with opioid agonist therapy is an effective microelimination strategy for people who inject drugs with high risk of non-adherence to direct-acting antiviral therapy
por: Schwarz, M., et al.
Publicado: (2023)

Trypanosomatid parasites in Austrian mosquitoes
por: Schoener, Ellen, et al.
Publicado: (2018)

Mortality and causes of death among patients with opioid use disorder receiving opioid agonist treatment: a national register study
por: Bech, Anne Berit, et al.
Publicado: (2019)

Effects of gatekeeper trainings from the Austrian national suicide prevention program
por: Plöderl, Martin, et al.
Publicado: (2023)

Alcohol use in opioid agonist treatment
por: Nolan, Seonaid, et al.
Publicado: (2016)

Therapeutic Potential of Kappa Opioid Agonists
por: Beck, Tyler C., et al.
Publicado: (2019)

Nasal administration of diacetylmorphine improved the adherence in a patient receiving heroin-assisted treatment
por: Meyer, Maximilian, et al.
Publicado: (2022)

Factors associated with physical and sexual violence by police among people who inject drugs in Ukraine: implications for retention on opioid agonist therapy
por: Kutsa, Oksana, et al.
Publicado: (2016)

Evaluating the association between urine drug screening frequency and retention in opioid agonist treatment in Ontario, Canada: a retrospective cohort study
por: Morin, Kristen A, et al.
Publicado: (2022)

Interim opioid agonist treatment for opioid addiction: a systematic review
por: Samsó Jofra, Laura, et al.
Publicado: (2022)

Austrian parliamentary representatives
por: CERN PhotoLab
Publicado: (1969)

Members of the Austrian Delegation
por: CERN PhotoLab
Publicado: (1975)

EOS at the Austrian T2
por: Seren, Umit, et al.
Publicado: (2021)

The Austrian Remedy for Cholera
por: Herapath, William
Publicado: (1851)

The Austrian UVA‐Network
por: Schmalwieser, Alois W., et al.
Publicado: (2019)

Prospects for Creation of Cardioprotective and Antiarrhythmic Drugs Based on Opioid Receptor Agonists
por: Maslov, Leonid N, et al.
Publicado: (2016)

Comparing rapid micro-induction and standard induction of buprenorphine/naloxone for treatment of opioid use disorder: protocol for an open-label, parallel-group, superiority, randomized controlled trial
por: Wong, James S. H., et al.
Publicado: (2021)

Memorandum by the Austrian Permanent Delegate to the European Office of the United Nations to the Finance Committee
Publicado: (1957)

Cannot write session to /tmp/vufind_sessions/sess_9l8mf78m956feqcqgbr6q07o95